Gene · 4038
Papers1,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Personality factors in patients with myasthenia gravis: A prospective study. | Brain Behav | 2023 | 37608592 | PubTator, text mining | PubMed |
| FcRN receptor antagonists in the management of myasthenia gravis. | Front Neurol | 2023 | 37602255 | PubTator, text mining | PubMed |
| Therapeutic and prognostic features in myasthenia gravis patients followed in a tertiary neuromuscular diseases center in Turkey. | Front Neurol | 2023 | 37602241 | PubTator, text mining | PubMed |
| Chromosome-level genome of butterflyfish unveils genomic features of unique colour patterns and morphological traits. | DNA Res | 2023 | 37590994 | PubTator, text mining | PubMed |
| Genome-wide association studies and fine-mapping identify genomic loci for n-3 and n-6 polyunsaturated fatty acids in Hispanic American and African American cohorts. | Commun Biol | 2023 | 37587153 | PubTator, text mining | PubMed |
| The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications. | J Mol Med (Berl) | 2023 | 37584739 | PubTator, text mining | PubMed |
| A single-cell atlas of in vitro multiculture systems uncovers the in vivo lineage trajectory and cell state in the human lung. | Exp Mol Med | 2023 | 37582976 | PubTator, text mining | PubMed |
| YAP/TAZ: Molecular pathway and disease therapy. | MedComm (2020) | 2023 | 37576865 | PubTator, text mining | PubMed |
| Impaired skeletal muscle health in Parkinsonian syndromes: clinical implications, mechanisms and potential treatments. | J Cachexia Sarcopenia Muscle | 2023 | 37574254 | PubTator, text mining | PubMed |
| Genetically predicted effects of physical activity and sedentary behavior on myasthenia gravis: evidence from mendelian randomization study. | BMC Neurol | 2023 | 37568096 | PubTator, text mining | PubMed |
| Autoimmune myasthenia gravis and COVID-19. A case report-based review. | J Int Med Res | 2023 | 37565671 | PubTator, text mining | PubMed |
| Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease. | Front Immunol | 2023 | 37564637 | PubTator, text mining | PubMed |
| A variant in the LDL receptor-related protein encoding gene LRP4 underlying polydactyly and phalangeal synostosis in a family of Pakistani origin. | Congenit Anom (Kyoto) | 2023 | 37563890 | PubTator, text mining | PubMed |
| Myasthenia gravis and congenital myasthenic syndromes. | Handb Clin Neurol | 2023 | 37562891 | PubTator, text mining | PubMed |
| New and emerging treatments for myasthenia gravis. | BMJ Med | 2023 | 37560511 | PubTator, text mining | PubMed |
| Polymorphism of LRP4 Gene (rs9667108) among Post Menopause Women with Osteoporosis. | Iran J Public Health | 2023 | 37551184 | PubTator, text mining | PubMed |
| Gut microbiota in muscular atrophy development, progression, and treatment: New therapeutic targets and opportunities. | Innovation (Camb) | 2023 | 37539440 | PubTator, text mining | PubMed |
| Causal effect of vitamin D on myasthenia gravis: a two-sample Mendelian randomization study. | Front Nutr | 2023 | 37538922 | PubTator, text mining | PubMed |
| Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development. | J Hum Genet | 2023 | 37537391 | PubTator, text mining | PubMed |
| Clinical Characteristics of Myasthenia Gravis Patients with COVID-19 in Guangxi, China: A Case-Control Study. | J Inflamm Res | 2023 | 37525635 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4038/papers?page=13